摘要:
springer.com
sci-hub.st 参考文章(79)
LC Hofbauer, CA Kuhne, V Viereck, The OPG/RANKL/RANK system in metabolic bone diseases. Journal of Musculoskeletal & Neuronal Interactions. ,vol. 4, pp. 268- 275 ,(2004)
J.-Y. Reginster, H. W. Minne, O. H. Sorensen, M. Hooper, C. Roux, M. L. Brandi, B. Lund, D. Ethgen, S. Pack, I. Roumagnac, R. Eastell, Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis Osteoporosis International. ,vol. 11, pp. 83- 91 ,(2000) , 10.1007/S001980050010
Young-Yun Kong, Hiroki Yoshida, Ildiko Sarosi, Hong-Lin Tan, Emma Timms, Casey Capparelli, Sean Morony, Antonio J. Oliveira-dos-Santos, Gwyneth Van, Annick Itie, Wilson Khoo, Andrew Wakeham, Colin R. Dunstan, David L. Lacey, Tak W. Mak, William J. Boyle, Josef M. Penninger, OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis Nature. ,vol. 397, pp. 315- 323 ,(1999) , 10.1038/16852
M.A Rodrı́guez-Martı́nez, E.C Garcı́a-Cohen, Role of Ca2+ and vitamin D in the prevention and treatment of osteoporosis Pharmacology & Therapeutics. ,vol. 93, pp. 37- 49 ,(2002) , 10.1016/S0163-7258(02)00164-X
Writing Group for the Women's Health Initiative Investigators, Writing Group for the Women's Health Initiative Investigators, None, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial JAMA. ,vol. 288, pp. 321- 333 ,(2002) , 10.1001/JAMA.288.3.321
B.L. Riggs, W.M. O'Fallon, A. Lane, S.F. Hodgson, H.W. Wahner, J. Muhs, E. Chao, L.J. Melton, Clinical trial of fluoride therapy in postmenopausal osteoporotic women: Extended observations and additional analysis Journal of Bone and Mineral Research. ,vol. 9, pp. 265- 275 ,(2009) , 10.1002/JBMR.5650090216
Robert Marcus, Mayme Wong, Hunter Heath, John L. Stock, Antiresorptive Treatment of Postmenopausal Osteoporosis: Comparison of Study Designs and Outcomes in Large Clinical Trials with Fracture as an Endpoint Endocrine Reviews. ,vol. 23, pp. 16- 37 ,(2002) , 10.1210/EDRV.23.1.0453
T. Schnitzer, , H. G. Bone, G. Crepaldi, S. Adami, M. McClung, D. Kiel, D. Felsenberg, R. R. Recker, R. P. Tonino, C. Roux, A. Pinchera, A. J. Foldes, S. L. Greenspan, M. A. Levine, R. Emkey, A. C. Santora, A. Kaur, D. E. Thompson, J. Yates, J. J. Orloff, Therapeutic equivalence of alendronate 70 mg onceweekly and alendronate 10 mg daily in the treatment of osteoporosis Aging Clinical and Experimental Research. ,vol. 12, pp. 1- 12 ,(2000) , 10.1007/BF03339822
Carolyn M. Klotzbuecher, Philip D. Ross, Pamela B. Landsman, Thomas A. Abbott, Marc Berger, Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis Journal of Bone and Mineral Research. ,vol. 15, pp. 721- 739 ,(2010) , 10.1359/JBMR.2000.15.4.721
Paul D. Miller, Daniel T. Baran, John P. Bilezikian, Susan L. Greenspan, Robert Lindsay, B. Lawrence Riggs, Nelson B. Watts, Practical Clinical Application of Biochemical Markers of Bone Turnover: Consensus of an Expert Panel Journal of Clinical Densitometry. ,vol. 2, pp. 323- 342 ,(1999) , 10.1385/JCD:2:3:323